Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.78 USD
Change Today +0.0051 / 0.66%
Volume 122.6K
As of 8:04 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eric A. Wachter Ph.D.

Chief Technology Officer and Executive Vice President, Provectus Biopharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

51$637,692
As of Fiscal Year 2014

Background*

Dr. Eric A. Wachter, Ph.D., has been the Chief Technology Officer of Provectus Pharmaceuticals, Inc. since May 14, 2012 and serves as its Executive Vice President. Dr. Wachter served as an Executive Vice President of Xantech Pharmaceuticals Inc. at Provectus Pharmaceuticals, Inc. from April 23, 2002 to May 14, 2012. Dr. Wachter served as Vice President of Pharmaceuticals of Provectus Pharmaceuticals Inc. since April 23, 2002. Prior to that, he was a Senior member of ...

Read Full Background

Corporate Headquarters*

7327 Oak Ridge Highway
Knoxville, Tennessee 37931

United States

Phone: 866-594-5999
Fax: 866-998-0005

Board Members Memberships*

1997-N/A
Former Vice president, Secretary and Director
2002-2012
Chief Technology Officer and Executive Vice President

Education*

PhD 1988
University of Wisconsin - Madison
BS
Indiana University, Bloomington

Other Affiliations*

Annual Compensation*

Salary$500,000
Total Annual Compensation$500,000

Stock Options*

All Other Compensation$137,692
Exercised Options639,248
Exercised Options Value$941,759
Exercisable Options1,185,000
Total Value of Options$941,759
Total Number of Options1,824,248

Total Compensation*

Total Annual Cash Compensation$637,692
Total Short Term Compensation$500,000
Other Long Term Compensation$137,692
Total Calculated Compensation$637,692
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PVCT:US $0.78 USD +0.0051

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROVECTUS BIOPHARMACEUTICA-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.